Second Sight Medical (EYES) Reports Q4 Loss of $0.17
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Second Sight Reports Fourth Quarter and Year End 2014 Financial Results and Provides Business Update
March 11, 2015 4:01 PM EDTSYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a leading developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today reported financial results for the three- and twelve- month periods ended December 31, 2014.
Recent Company Highlights:
As a result of the IPO that successfully raised $34.0 million in net proceeds and the conversion of all outstanding debt into common stock, the Company now has a strong balance sheet with $34.6 million in cash and... More